Genomics Personalized Health Global Market Report 2025

Description

Genomics personalized health involves customizing medical care and treatments based on an individual's genomic data, taking into account their specific genetic characteristics, lifestyle choices, and environmental factors. This method utilizes progress in genomics, bioinformatics, and personalized medicine to offer more accurate and efficient healthcare solutions personalized to each person's genetic inclinations, susceptibilities, and responses to treatment.

The primary test types of genomics personalized health comprise oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, and others. Oncology testing involves employing genetic testing methods to identify cancer and ascertain its unique attributes, utilizing technologies such as NGS platforms, RT-PCR, microarray, and genetic analyzers. These tests cater to end users such as academic research institutes, diagnostic centers, and others.

The genomics personalized health market research report is one of a series of new reports from The Business Research Company that provides genomics personalized health market statistics, including the genomics personalized health industry global market size, regional shares, competitors with genomics personalized health market share, detailed genomics personalized health market segments, market trends, and opportunities, and any further data you may need to thrive in the genomics personalized health industry. These genomics personalized health market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genomics personalized health market size has grown rapidly in recent years. It will grow from $15.97 billion in 2024 to $18.58 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to advancements in genomics research, government funding, and support, a rise in chronic diseases, technological innovations, pharmaceutical industry investment, collaborations, and partnerships.

The genomics personalized health market size is expected to see rapid growth in the next few years. It will grow to $33.6 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to increasing healthcare investments, growing adoption of genomics technologies, expanding applications of personalized medicine, rising prevalence of genetic disorders, expansion of biobanks, and increasing prevalence of chronic diseases. Major trends in the forecast period include integration with wearable technology, growth of direct-to-consumer genetic testing, advancements in CRISPR and gene editing, integration of genomics with digital health, and expansion of precision medicine initiatives.

The increasing interest in personalized medicine is poised to drive the expansion of the genomics personalized health market in the future. Personalized medicine, also referred to as precision medicine, revolutionizes healthcare by customizing medical interventions to suit the unique characteristics of individual patients. The surge in demand for personalized medicine stems from a transition towards preventive healthcare, enhanced treatment outcomes, heightened patient involvement and empowerment, economic advantages, and the escalating prevalence of chronic and intricate ailments. Genomics personalized health plays a pivotal role in advancing personalized medicine by harnessing individual genetic data to tailor medical interventions, spanning from preventive measures and diagnosis to treatment and monitoring. For example, in February 2024, as reported by the Personalized Medicine Coalition, a non-profit organization based in the US, the Food and Drug Administration (FDA) sanctioned 16 innovative personalized therapies for rare diseases in 2023, in contrast to six in 2022. Hence, the escalating demand for personalized medicine underpins the growth of the genomics personalized health market.

Leading companies in the genomics personalized health market are focusing on developing innovative products, such as cloud-based software for tertiary analysis of clinical next-generation sequencing (NGS) data, to gain a competitive edge. Clinical NGS data refers to genetic information obtained through sequencing technologies, enabling high-throughput, detailed analysis of DNA or RNA samples in clinical settings. For example, in March 2023, Illumina, a US-based biotechnology company specializing in DNA sequencing and array-based technologies, launched Connected Insights, a cloud-based software designed for the tertiary analysis of clinical NGS data. This platform aims to optimize the interpretation and reporting processes, particularly for oncology applications, and supports comprehensive genomic profiling. Connected Insights integrates various third-party knowledge bases, facilitating accurate data analysis and improving the efficiency of precision care initiatives.

In January 2022, Exact Sciences Corp., a US-based biotechnology research company, completed the acquisition of PreventionGenetics for an undisclosed sum. This strategic move was intended to enhance Exact Sciences' capabilities in cancer screening and diagnostics, with a specific focus on hereditary cancer testing, in order to further the cause of personalized healthcare and promote early cancer detection. PreventionGenetics, also based in the US, is a biotechnology research company specializing in genomics personalized health.

Major companies operating in the genomics personalized health market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Quest Diagnostics, Agilent Technologies Inc., Lonza Group, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V, Natera Inc., Adaptive Biotechnologies Corporation, Myriad Genetics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Personalis Inc., DNA Genotek Inc., Twist Bioscience Corporation, GRAIL Inc., Eastern Biotech and Life Sciences, INVITAE Corporation, Genetic Technologies Limited, XCode Life Sciences Private Limited, Biome Inc., BGI Genomics Co. Ltd.

North America was the largest region in the personalized health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics personalized health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the genomics personalized health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The genomics personalized health market consists of revenues earned by entities by providing services such as genomic sequencing, bioinformatics analysis, genetic testing, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomics personalized health market also includes sales of DNA sequencing kits, genomic data management solutions, pharmacogenomics tests, personalized wellness and nutrition products, and companion diagnostics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomics Personalized Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomics personalized health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomics personalized health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomics personalized health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Test Type: Oncology Testing; Infectious Disease Testing; Orphan Disease Testing; Autoimmune Disease Testing; Obstetrics Testing; Other Test Type
2) By Technology: NGS platforms; RT-PCR; Microarray; Genetic Analyzers
3) By End User: Academic Research Institutes; Diagnostic Centers; Other End Users
Subsegments:
1) Oncology Testing: Cancer Genomic Profiling; Liquid Biopsy Testing; Tumor Mutational Burden Testing; Genetic Biomarker Testing
2) Infectious Disease Testing: PCR-Based Tests; Next-Generation Sequencing (NGS) Tests; Microbial Genomic Profiling
3) Orphan Disease Testing: Genetic Screening For Rare Diseases; Genetic Testing For Inherited Disorders; Targeted Gene Panels
4) Autoimmune Disease Testing: Genetic Screening For Autoimmune Conditions; Immune System Gene Profiling; HLA Typing Tests
5) Obstetrics Testing: Non-Invasive Prenatal Testing (NIPT); Genetic Screening For Birth Defects; Carrier Screening Tests
6) Other Test Type: Cardiovascular Genetic Testing; Neurological Disease Testing; Metabolic Disease Genetic Testing
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Quest Diagnostics; Agilent Technologies Inc.; Lonza Group
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r30315

1. Executive Summary

2. Genomics Personalized Health Market Characteristics

3. Genomics Personalized Health Market Trends And Strategies

4. Genomics Personalized Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Genomics Personalized Health Growth Analysis And Strategic Analysis Framework

5.1. Global Genomics Personalized Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Genomics Personalized Health Market Growth Rate Analysis
5.4. Global Genomics Personalized Health Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Genomics Personalized Health Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Genomics Personalized Health Total Addressable Market (TAM)

6. Genomics Personalized Health Market Segmentation

6.1. Global Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology Testing
Infectious Disease Testing
Orphan Disease Testing
Autoimmune Disease Testing
Obstetrics Testing
Other Test Type
6.2. Global Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
NGS platforms
RT-PCR
Microarray
Genetic Analyzers
6.3. Global Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Academic Research Institutes
Diagnostic Centers
Other End User
6.4. Global Genomics Personalized Health Market, Sub-Segmentation Of Oncology Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Genomic Profiling
Liquid Biopsy Testing
Tumor Mutational Burden Testing
Genetic Biomarker Testing
6.5. Global Genomics Personalized Health Market, Sub-Segmentation Of Infectious Disease Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PCR-Based Tests
Next-Generation Sequencing (NGS) Tests
Microbial Genomic Profiling
6.6. Global Genomics Personalized Health Market, Sub-Segmentation Of Orphan Disease Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Screening For Rare Diseases
Genetic Testing For Inherited Disorders
Targeted Gene Panels
6.7. Global Genomics Personalized Health Market, Sub-Segmentation Of Autoimmune Disease Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Screening For Autoimmune Conditions
Immune System Gene Profiling
HLA Typing Tests
6.8. Global Genomics Personalized Health Market, Sub-Segmentation Of Obstetrics Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Invasive Prenatal Testing (NIPT)
Genetic Screening For Birth Defects
Carrier Screening Tests
6.9. Global Genomics Personalized Health Market, Sub-Segmentation Of Other Test Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular Genetic Testing
Neurological Disease Testing
Metabolic Disease Genetic Testing

7. Genomics Personalized Health Market Regional And Country Analysis

7.1. Global Genomics Personalized Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Genomics Personalized Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomics Personalized Health Market

8.1. Asia-Pacific Genomics Personalized Health Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomics Personalized Health Market

9.1. China Genomics Personalized Health Market Overview
9.2. China Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomics Personalized Health Market

10.1. India Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomics Personalized Health Market

11.1. Japan Genomics Personalized Health Market Overview
11.2. Japan Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomics Personalized Health Market

12.1. Australia Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomics Personalized Health Market

13.1. Indonesia Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomics Personalized Health Market

14.1. South Korea Genomics Personalized Health Market Overview
14.2. South Korea Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomics Personalized Health Market

15.1. Western Europe Genomics Personalized Health Market Overview
15.2. Western Europe Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomics Personalized Health Market

16.1. UK Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomics Personalized Health Market

17.1. Germany Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomics Personalized Health Market

18.1. France Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomics Personalized Health Market

19.1. Italy Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomics Personalized Health Market

20.1. Spain Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomics Personalized Health Market

21.1. Eastern Europe Genomics Personalized Health Market Overview
21.2. Eastern Europe Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomics Personalized Health Market

22.1. Russia Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomics Personalized Health Market

23.1. North America Genomics Personalized Health Market Overview
23.2. North America Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomics Personalized Health Market

24.1. USA Genomics Personalized Health Market Overview
24.2. USA Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomics Personalized Health Market

25.1. Canada Genomics Personalized Health Market Overview
25.2. Canada Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomics Personalized Health Market

26.1. South America Genomics Personalized Health Market Overview
26.2. South America Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomics Personalized Health Market

27.1. Brazil Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomics Personalized Health Market

28.1. Middle East Genomics Personalized Health Market Overview
28.2. Middle East Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomics Personalized Health Market

29.1. Africa Genomics Personalized Health Market Overview
29.2. Africa Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomics Personalized Health Market Competitive Landscape And Company Profiles

30.1. Genomics Personalized Health Market Competitive Landscape
30.2. Genomics Personalized Health Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Lonza Group Overview, Products and Services, Strategy and Financial Analysis

31. Genomics Personalized Health Market Other Major And Innovative Companies

31.1. PerkinElmer Inc.
31.2. Illumina Inc.
31.3. Bio-Rad Laboratories Inc.
31.4. Exact Sciences Corporation
31.5. QIAGEN N.V
31.6. Natera Inc.
31.7. Adaptive Biotechnologies Corporation
31.8. Myriad Genetics Inc.
31.9. NanoString Technologies Inc.
31.10. Pacific Biosciences of California Inc.
31.11. Personalis Inc.
31.12. DNA Genotek Inc.
31.13. Twist Bioscience Corporation
31.14. GRAIL Inc.
31.15. Eastern Biotech and Life Sciences

32. Global Genomics Personalized Health Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomics Personalized Health Market

34. Recent Developments In The Genomics Personalized Health Market

35. Genomics Personalized Health Market High Potential Countries, Segments and Strategies

35.1 Genomics Personalized Health Market In 2029 - Countries Offering Most New Opportunities
35.2 Genomics Personalized Health Market In 2029 - Segments Offering Most New Opportunities
35.3 Genomics Personalized Health Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer